NPS's Nader on Drug Research, Growth Strategy

Feb. 25 (Bloomberg) -- Francois Nader, chief excutive officer for NPS Pharmaceuticals Inc., talks about cost strategy and product development. Nader speaks with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance." Stanley Collender, managing director for Qorvis Communications LLC, also speaks. (Source: Bloomberg)

Tesla 4Q Revenue Lighter Than Analyst Estimates
30:54 - Bloomberg's Scarlet Fu and Cory Johnson report on Tesla earnings for the fourth-quarter. They speak on "What'd You Miss?" (Source: Bloomberg)
  • Deep Dive: Why the Selloff Is Steeper in 5-Year Yield
  • Can Tesla Reverse Its Share Slump?
  • Options Insight: How to Play Texas Instruments